首页 > 最新文献

Circulation: Heart Failure最新文献

英文 中文
Single Arterial Access for VA-ECMO-Assisted Stenting of a Left Ventricular Assist Device Outflow Graft Obstruction in the Setting of an Oversewn Aortic Valve. 在主动脉瓣膜外缝合的情况下,为 VA-ECMO 辅助支架植入左心室辅助装置流出道阻塞的单动脉入路。
IF 7.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-01 Epub Date: 2024-10-09 DOI: 10.1161/CIRCHEARTFAILURE.124.011743
Navin K Kapur, Michael S Kiernan, Nicolas Ruiz, Haval Chweich
{"title":"Single Arterial Access for VA-ECMO-Assisted Stenting of a Left Ventricular Assist Device Outflow Graft Obstruction in the Setting of an Oversewn Aortic Valve.","authors":"Navin K Kapur, Michael S Kiernan, Nicolas Ruiz, Haval Chweich","doi":"10.1161/CIRCHEARTFAILURE.124.011743","DOIUrl":"10.1161/CIRCHEARTFAILURE.124.011743","url":null,"abstract":"","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":" ","pages":"e011743"},"PeriodicalIF":7.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142388502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Equity in Heart Failure Care: A Get With the Guidelines Analysis of Between- and Within-Hospital Differences in Care by Sex, Race, Ethnicity, and Insurance. 心力衰竭护理的公平性:根据指南分析不同性别、种族、人种和保险在医院之间和医院内部的护理差异》(Get With the Guidelines Analysis of Between and Within-Hospital Differences in Care by Sex, Race, Ethnicity, and Insurance)。
IF 9.7 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-18 DOI: 10.1161/circheartfailure.123.011177
Alexander T Sandhu,Maria V Grau-Sepulveda,Celeste Witting,Rebecca L Tisdale,Jimmy Zheng,Fatima Rodriguez,Justin A Edward,Andrew P Ambrosy,Stephen J Greene,Brooke Alhanti,Gregg C Fonarow,Karen E Joynt Maddox,Paul A Heidenreich
BACKGROUNDDisparities in guideline-based quality measures likely contribute to differences in heart failure (HF) outcomes. We evaluated between- and within-hospital differences in the quality of care across sex, race, ethnicity, and insurance for patients hospitalized for HF.METHODSThis retrospective analysis included patients hospitalized for HF across 596 hospitals in the Get With the Guidelines-HF registry between 2016 and 2021. We evaluated performance across 7 measures stratified by patient sex, race, ethnicity, and insurance. We evaluated differences in performance with and without adjustment for the treating hospital. We also measured variation in hospital-specific disparities.RESULTSAmong 685 227 patients, the median patient age was 72 (interquartile range, 61-82) and 47.2% were women. Measure performance was significantly lower (worse) for women compared with men for all 7 measures before adjustment. For 4 of 7 measures, there were no significant sex-related differences after patient-level adjustment. For 20 of 25 other comparisons, racial and ethnic minorities and Medicaid/uninsured patients had similar or higher (better) adjusted measure performance compared with White and Medicare/privately insured patients, respectively. Angiotensin receptor neprilysin inhibitor measure performance was significantly lower for Asian, Hispanic, and Medicaid/uninsured patients, and cardiac resynchronization therapy implant/prescription was lower among women and Black patients after hospital adjustment, indicating within-hospital differences. There was hospital-level variation in these differences. For cardiac resynchronization therapy implantation/prescription, 278 hospitals (46.6%) had ≥2% lower implant/prescription for Black versus White patients compared with 109 hospitals (18.3%) with the same or higher cardiac resynchronization therapy implantation/prescription for Black patients.CONCLUSIONSHF quality measure performance was equitable for most measures. There were within-hospital differences in angiotensin receptor neprilysin inhibitor and cardiac resynchronization therapy implant/prescription for historically marginalized groups. The magnitude of hospital-specific disparities varied across hospitals.
背景基于指南的质量衡量标准的差异很可能导致心力衰竭(HF)结果的不同。我们评估了不同性别、种族、民族和保险的心力衰竭住院患者在医院间和医院内的医疗质量差异。方法这项回顾性分析纳入了 2016 年至 2021 年期间在《Get With the Guidelines-HF 》登记处的 596 家医院住院的心力衰竭患者。我们评估了按患者性别、种族、民族和保险分层的 7 项措施的绩效。我们评估了对治疗医院进行调整和未进行调整的绩效差异。结果在 685 227 名患者中,患者年龄中位数为 72 岁(四分位间范围为 61-82),47.2% 为女性。在调整前的所有 7 项测量中,女性的测量绩效明显低于男性(更差)。对于 7 项测量中的 4 项,在对患者水平进行调整后,与性别相关的差异并不明显。在其他 25 项比较中的 20 项比较中,少数种族和少数民族以及医疗补助/无保险患者与白人和医疗保险/私人保险患者相比,其调整后的测量结果分别相似或更高(更好)。经医院调整后,亚裔、西班牙裔和医疗补助/未参保患者的血管紧张素受体肾素抑制剂测量绩效明显较低,女性和黑人患者的心脏再同步化治疗植入/处方绩效较低,这表明医院内部存在差异。这些差异存在医院层面的差异。在心脏再同步化治疗植入/处方方面,278 家医院(46.6%)的黑人患者植入/处方比白人患者低≥2%,而 109 家医院(18.3%)的黑人患者心脏再同步化治疗植入/处方与白人患者相同或更高。历史上被边缘化的群体在血管紧张素受体肾素抑制剂和心脏再同步疗法植入/处方方面存在院内差异。各家医院的具体差异程度不尽相同。
{"title":"Equity in Heart Failure Care: A Get With the Guidelines Analysis of Between- and Within-Hospital Differences in Care by Sex, Race, Ethnicity, and Insurance.","authors":"Alexander T Sandhu,Maria V Grau-Sepulveda,Celeste Witting,Rebecca L Tisdale,Jimmy Zheng,Fatima Rodriguez,Justin A Edward,Andrew P Ambrosy,Stephen J Greene,Brooke Alhanti,Gregg C Fonarow,Karen E Joynt Maddox,Paul A Heidenreich","doi":"10.1161/circheartfailure.123.011177","DOIUrl":"https://doi.org/10.1161/circheartfailure.123.011177","url":null,"abstract":"BACKGROUNDDisparities in guideline-based quality measures likely contribute to differences in heart failure (HF) outcomes. We evaluated between- and within-hospital differences in the quality of care across sex, race, ethnicity, and insurance for patients hospitalized for HF.METHODSThis retrospective analysis included patients hospitalized for HF across 596 hospitals in the Get With the Guidelines-HF registry between 2016 and 2021. We evaluated performance across 7 measures stratified by patient sex, race, ethnicity, and insurance. We evaluated differences in performance with and without adjustment for the treating hospital. We also measured variation in hospital-specific disparities.RESULTSAmong 685 227 patients, the median patient age was 72 (interquartile range, 61-82) and 47.2% were women. Measure performance was significantly lower (worse) for women compared with men for all 7 measures before adjustment. For 4 of 7 measures, there were no significant sex-related differences after patient-level adjustment. For 20 of 25 other comparisons, racial and ethnic minorities and Medicaid/uninsured patients had similar or higher (better) adjusted measure performance compared with White and Medicare/privately insured patients, respectively. Angiotensin receptor neprilysin inhibitor measure performance was significantly lower for Asian, Hispanic, and Medicaid/uninsured patients, and cardiac resynchronization therapy implant/prescription was lower among women and Black patients after hospital adjustment, indicating within-hospital differences. There was hospital-level variation in these differences. For cardiac resynchronization therapy implantation/prescription, 278 hospitals (46.6%) had ≥2% lower implant/prescription for Black versus White patients compared with 109 hospitals (18.3%) with the same or higher cardiac resynchronization therapy implantation/prescription for Black patients.CONCLUSIONSHF quality measure performance was equitable for most measures. There were within-hospital differences in angiotensin receptor neprilysin inhibitor and cardiac resynchronization therapy implant/prescription for historically marginalized groups. The magnitude of hospital-specific disparities varied across hospitals.","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":"48 1","pages":"e011177"},"PeriodicalIF":9.7,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142255579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response by Kanaoka et al to Letter Regarding Article, "Changes in Cardiac Function Following Fulminant Myocarditis". Kanaoka 等人对有关 "暴发性心肌炎后心功能的变化 "一文的回信。
IF 7.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 Epub Date: 2024-08-20 DOI: 10.1161/CIRCHEARTFAILURE.124.012029
Koshiro Kanaoka, Kenji Onoue, Yoshihiko Saito
{"title":"Response by Kanaoka et al to Letter Regarding Article, \"Changes in Cardiac Function Following Fulminant Myocarditis\".","authors":"Koshiro Kanaoka, Kenji Onoue, Yoshihiko Saito","doi":"10.1161/CIRCHEARTFAILURE.124.012029","DOIUrl":"10.1161/CIRCHEARTFAILURE.124.012029","url":null,"abstract":"","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":" ","pages":"e012029"},"PeriodicalIF":7.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142003734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reflections on the Win Ratio With Time-to-Event Outcomes. 对时间-事件结果胜率的思考。
IF 7.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 Epub Date: 2024-08-28 DOI: 10.1161/CIRCHEARTFAILURE.124.012186
Janet Wittes
{"title":"Reflections on the Win Ratio With Time-to-Event Outcomes.","authors":"Janet Wittes","doi":"10.1161/CIRCHEARTFAILURE.124.012186","DOIUrl":"10.1161/CIRCHEARTFAILURE.124.012186","url":null,"abstract":"","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":" ","pages":"e012186"},"PeriodicalIF":7.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142079350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Characteristics and Outcomes of Patients Suffering Acute Decompensated Heart Failure Complicated by Cardiogenic Shock. 急性失代偿性心力衰竭并发心源性休克患者的临床特征和预后。
IF 7.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 Epub Date: 2024-08-29 DOI: 10.1161/CIRCHEARTFAILURE.123.011358
Christos P Kyriakopoulos, Konstantinos Sideris, Iosif Taleb, Eleni Maneta, Rana Hamouche, Eleni Tseliou, Chong Zhang, Angela P Presson, Elizabeth Dranow, Kevin S Shah, Tara L Jones, James C Fang, Josef Stehlik, Craig H Selzman, Matthew L Goodwin, Joseph E Tonna, Thomas C Hanff, Stavros G Drakos

Background: Cardiogenic shock (CS) can stem from multiple causes and portends poor prognosis. Prior studies have focused on acute myocardial infarction-CS; however, acute decompensated heart failure (ADHF)-CS accounts for most cases. We studied patients suffering ADHF-CS to identify clinical factors, early in their trajectory, associated with a higher probability of successful outcomes.

Methods: Consecutive patients with CS were evaluated (N=1162). We studied patients who developed ADHF-CS at our hospital (N=562). Primary end point was native heart survival (NHS), defined as survival to discharge without receiving advanced HF therapies. Secondary end points were adverse events, survival, major cardiac interventions, and hospital readmissions within 1 year following index hospitalization discharge. Association of clinical data with NHS was analyzed using logistic regression.

Results: Overall, 357 (63.5%) patients achieved NHS, 165 (29.2%) died, and 41 (7.3%) were discharged post advanced HF therapies. Of 398 discharged patients (70.8%), 303 (53.9%) were alive at 1 year. Patients with NHS less commonly suffered cardiac arrest, underwent intubation or pulmonary artery catheter placement, or received temporary mechanical circulatory support, had better hemodynamic and echocardiographic profiles, and had a lower vasoactive-inotropic score at shock onset. Bleeding, hemorrhagic stroke, hemolysis in patients with mechanical circulatory support, and acute kidney injury requiring renal replacement therapy were less common compared with patients who died or received advanced HF therapies. After multivariable adjustments, clinical variables associated with NHS likelihood included younger age, history of systemic hypertension, absence of cardiac arrest or acute kidney injury requiring renal replacement therapy, lower pulmonary capillary wedge pressure and vasoactive-inotropic score, and higher tricuspid annular plane systolic excursion at shock onset (all P<0.05).

Conclusions: By studying contemporary patients with ADHF-CS, we identified clinical factors that can inform clinical management and provide future research targets. Right ventricular function, renal function, pulmonary artery catheter placement, and type and timing of temporary mechanical circulatory support warrant further investigation to improve outcomes of this devastating condition.

背景:心源性休克(CS)可由多种原因引起,预后不良。之前的研究主要集中在急性心肌梗死-CS,但急性失代偿性心力衰竭(ADHF)-CS占大多数病例。我们对急性失代偿性心力衰竭-CS 患者进行了研究,以确定在其生命轨迹的早期,与更高成功概率相关的临床因素:评估了连续的 CS 患者(N=1162)。我们研究了本医院的 ADHF-CS 患者(562 人)。主要终点是原发性心脏存活率(NHS),即在未接受高级 HF 治疗的情况下出院后的存活率。次要终点是不良事件、存活率、主要心脏介入治疗以及指数住院出院后 1 年内的再住院率。采用逻辑回归分析了临床数据与 NHS 的关系:总体而言,357 名(63.5%)患者达到了 NHS,165 名(29.2%)患者死亡,41 名(7.3%)患者在接受晚期 HF 治疗后出院。在398名出院患者(70.8%)中,有303人(53.9%)在1年内存活。接受 NHS 治疗的患者较少发生心脏骤停、接受插管或肺动脉导管置入术或接受临时机械循环支持,其血液动力学和超声心动图情况较好,休克发生时血管活性-肌力评分较低。与死亡或接受晚期心衰治疗的患者相比,出血、出血性中风、机械循环支持患者溶血以及需要肾脏替代治疗的急性肾损伤的发生率较低。经过多变量调整后,与 NHS 可能性相关的临床变量包括:年龄较小、有系统性高血压病史、没有心脏骤停或急性肾损伤需要肾脏替代治疗、肺毛细血管楔压和血管活性-肌张力评分较低、休克发生时三尖瓣环平面收缩期偏移较高(均为 PConclusions):通过对当代 ADHF-CS 患者的研究,我们发现了一些临床因素,这些因素可以为临床管理提供依据,并为未来的研究提供目标。右心室功能、肾功能、肺动脉导管置入以及临时机械循环支持的类型和时机值得进一步研究,以改善这种灾难性疾病的预后。
{"title":"Clinical Characteristics and Outcomes of Patients Suffering Acute Decompensated Heart Failure Complicated by Cardiogenic Shock.","authors":"Christos P Kyriakopoulos, Konstantinos Sideris, Iosif Taleb, Eleni Maneta, Rana Hamouche, Eleni Tseliou, Chong Zhang, Angela P Presson, Elizabeth Dranow, Kevin S Shah, Tara L Jones, James C Fang, Josef Stehlik, Craig H Selzman, Matthew L Goodwin, Joseph E Tonna, Thomas C Hanff, Stavros G Drakos","doi":"10.1161/CIRCHEARTFAILURE.123.011358","DOIUrl":"10.1161/CIRCHEARTFAILURE.123.011358","url":null,"abstract":"<p><strong>Background: </strong>Cardiogenic shock (CS) can stem from multiple causes and portends poor prognosis. Prior studies have focused on acute myocardial infarction-CS; however, acute decompensated heart failure (ADHF)-CS accounts for most cases. We studied patients suffering ADHF-CS to identify clinical factors, early in their trajectory, associated with a higher probability of successful outcomes.</p><p><strong>Methods: </strong>Consecutive patients with CS were evaluated (N=1162). We studied patients who developed ADHF-CS at our hospital (N=562). Primary end point was native heart survival (NHS), defined as survival to discharge without receiving advanced HF therapies. Secondary end points were adverse events, survival, major cardiac interventions, and hospital readmissions within 1 year following index hospitalization discharge. Association of clinical data with NHS was analyzed using logistic regression.</p><p><strong>Results: </strong>Overall, 357 (63.5%) patients achieved NHS, 165 (29.2%) died, and 41 (7.3%) were discharged post advanced HF therapies. Of 398 discharged patients (70.8%), 303 (53.9%) were alive at 1 year. Patients with NHS less commonly suffered cardiac arrest, underwent intubation or pulmonary artery catheter placement, or received temporary mechanical circulatory support, had better hemodynamic and echocardiographic profiles, and had a lower vasoactive-inotropic score at shock onset. Bleeding, hemorrhagic stroke, hemolysis in patients with mechanical circulatory support, and acute kidney injury requiring renal replacement therapy were less common compared with patients who died or received advanced HF therapies. After multivariable adjustments, clinical variables associated with NHS likelihood included younger age, history of systemic hypertension, absence of cardiac arrest or acute kidney injury requiring renal replacement therapy, lower pulmonary capillary wedge pressure and vasoactive-inotropic score, and higher tricuspid annular plane systolic excursion at shock onset (all <i>P</i><0.05).</p><p><strong>Conclusions: </strong>By studying contemporary patients with ADHF-CS, we identified clinical factors that can inform clinical management and provide future research targets. Right ventricular function, renal function, pulmonary artery catheter placement, and type and timing of temporary mechanical circulatory support warrant further investigation to improve outcomes of this devastating condition.</p>","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":" ","pages":"e011358"},"PeriodicalIF":7.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11490875/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142104854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eosinophilic Myocarditis in a Patient With Systemic Lupus Erythematosus and P-Neutrophil Cytoplasmic Antibodies Associated Vasculitis Overlap. 系统性红斑狼疮患者的嗜酸性粒细胞性心肌炎与 P 中性粒细胞胞浆抗体相关性血管炎重叠
IF 7.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 Epub Date: 2024-08-28 DOI: 10.1161/CIRCHEARTFAILURE.124.011612
Roger Winters, Alex Grubb, Ramon Eldermire, Erin McGuinn, Natasha Altman, William K Cornwell
{"title":"Eosinophilic Myocarditis in a Patient With Systemic Lupus Erythematosus and P-Neutrophil Cytoplasmic Antibodies Associated Vasculitis Overlap.","authors":"Roger Winters, Alex Grubb, Ramon Eldermire, Erin McGuinn, Natasha Altman, William K Cornwell","doi":"10.1161/CIRCHEARTFAILURE.124.011612","DOIUrl":"10.1161/CIRCHEARTFAILURE.124.011612","url":null,"abstract":"","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":" ","pages":"e011612"},"PeriodicalIF":7.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142079348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter by Monda and Limongelli Regarding Article, "Changes in Cardiac Function Following Fulminant Myocarditis". Monda 和 Limongelli 就 "暴发性心肌炎后心功能的变化 "一文的来信。
IF 7.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 Epub Date: 2024-08-20 DOI: 10.1161/CIRCHEARTFAILURE.124.011987
Emanuele Monda, Giuseppe Limongelli
{"title":"Letter by Monda and Limongelli Regarding Article, \"Changes in Cardiac Function Following Fulminant Myocarditis\".","authors":"Emanuele Monda, Giuseppe Limongelli","doi":"10.1161/CIRCHEARTFAILURE.124.011987","DOIUrl":"10.1161/CIRCHEARTFAILURE.124.011987","url":null,"abstract":"","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":" ","pages":"e011987"},"PeriodicalIF":7.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142003733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heart Failure With Preserved Ejection Fraction: From a Vascular Perspective. 保留射血分数的心力衰竭:从血管角度看心衰
IF 7.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 Epub Date: 2024-09-09 DOI: 10.1161/CIRCHEARTFAILURE.124.012187
Guillaume Goudot, Marie Denise Gerhard-Herman
{"title":"Heart Failure With Preserved Ejection Fraction: From a Vascular Perspective.","authors":"Guillaume Goudot, Marie Denise Gerhard-Herman","doi":"10.1161/CIRCHEARTFAILURE.124.012187","DOIUrl":"10.1161/CIRCHEARTFAILURE.124.012187","url":null,"abstract":"","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":" ","pages":"e012187"},"PeriodicalIF":7.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142153260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rising Tide (Unfortunately) Lifts All Boats: Elucidating the Relationship Between Cardiac Filling Pressures and Pleural Effusions. 涨潮(不幸地)让所有船只起航:阐明心脏充盈压与胸腔积液之间的关系。
IF 7.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 Epub Date: 2024-08-06 DOI: 10.1161/CIRCHEARTFAILURE.124.012126
Raymond C Parrish, Kai E Swenson
{"title":"A Rising Tide (Unfortunately) Lifts All Boats: Elucidating the Relationship Between Cardiac Filling Pressures and Pleural Effusions.","authors":"Raymond C Parrish, Kai E Swenson","doi":"10.1161/CIRCHEARTFAILURE.124.012126","DOIUrl":"10.1161/CIRCHEARTFAILURE.124.012126","url":null,"abstract":"","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":" ","pages":"e012126"},"PeriodicalIF":7.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141892998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pleural Effusion and Invasive Hemodynamic Measurements in Advanced Heart Failure. 晚期心力衰竭的胸腔积液和有创血流动力学测量。
IF 7.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 Epub Date: 2024-08-06 DOI: 10.1161/CIRCHEARTFAILURE.123.011253
Signe Glargaard, Tania Deis, Annemette G Abild-Nielsen, Alexander Stark, Jakob H Thomsen, Søren L Kristensen, Kasper Rossing, Finn Gustafsson, Jens Jakob Thune

Background: Pleural effusion is present in 50% to 80% of patients with acute heart failure, depending on image modality. We aim to describe the association between the presence and size of pleural effusion and central hemodynamics, including pulmonary capillary wedge pressure (PCWP) in an advanced heart failure population.

Methods: An observational, cross-sectional study in a cohort of patients with advanced heart failure (left ventricular ejection fraction ≤45%) who underwent right heart catheterization at The Department of Cardiology at Copenhagen University Hospital, Rigshospitalet, Denmark, between January 1, 2002 and October 31, 2020. The presence and size of pleural effusion were determined by a semiquantitative score of chest x-rays or computed tomography scans performed within 2 days of right heart catheterization.

Results: In 346 patients (50±13 years; 78% males) with median left ventricular ejection fraction of 20% (15-25), we identified 162 (47%) with pleural effusion. The pleural effusion size was medium in 38 (24%) and large in 30 (19%). Patients with pleural effusion had a 4.3 mm Hg (2.5-6.1) higher PCWP and 2.4 mm Hg (1.2-3.6) higher central venous pressure (P<0.001 for both). Patients with a medium/large pleural effusion had statistically significantly higher filling pressures than patients with a small effusion. Higher PCWP (odds ratio [OR], 1.06 [1.03-1.10]) and central venous pressure (OR, 1.09 [1.05-1.15]) were associated with pleural effusion in multivariable logistic regression adjusted for age, sex, and heart failure medications (P<0.001 for both). In a subgroup of 204 (63%) patients with serum albumin data, PCWP (OR, 1.06 [1.01-1.11]; P=0.032), central venous pressure (OR, 1.14 [1.06-1.23]; P<0.001) and serum albumin level (OR, 0.89 [0.83-0.95]; P<0.001) were independently associated with the presence of a medium/large-sized pleural effusion.

Conclusions: In patients with left ventricular ejection fraction ≤45% undergoing right heart catheterization as part of advanced heart failure work-up, pleural effusion was associated with higher PCWP and central venous pressure and lower serum albumin.

背景:50%到80%的急性心力衰竭患者存在胸腔积液,这取决于图像模式。我们旨在描述晚期心衰患者胸腔积液的存在和大小与中心血流动力学(包括肺毛细血管楔压(PCWP))之间的关系:方法:对2002年1月1日至2020年10月31日期间在丹麦哥本哈根大学医院(Rigshospitalet)心内科接受右心导管检查的晚期心衰患者(左心室射血分数≤45%)进行横断面观察研究。胸腔积液的存在和大小通过右心导管检查后 2 天内进行的胸部 X 光片或计算机断层扫描的半定量评分来确定:在346名左心室射血分数中位数为20%(15-25)的患者(50±13岁;78%为男性)中,我们发现162人(47%)有胸腔积液。38例(24%)胸腔积液为中型,30例(19%)为大型。胸腔积液患者的 PCWP 高 4.3 mm Hg(2.5-6.1),中心静脉压高 2.4 mm Hg(1.2-3.6)(PPP=0.032),中心静脉压(OR,1.14 [1.06-1.23];PPConclusions:左室射血分数≤45%的患者在接受右心导管检查作为晚期心衰检查的一部分时,胸腔积液与较高的PCWP和中心静脉压以及较低的血清白蛋白有关。
{"title":"Pleural Effusion and Invasive Hemodynamic Measurements in Advanced Heart Failure.","authors":"Signe Glargaard, Tania Deis, Annemette G Abild-Nielsen, Alexander Stark, Jakob H Thomsen, Søren L Kristensen, Kasper Rossing, Finn Gustafsson, Jens Jakob Thune","doi":"10.1161/CIRCHEARTFAILURE.123.011253","DOIUrl":"10.1161/CIRCHEARTFAILURE.123.011253","url":null,"abstract":"<p><strong>Background: </strong>Pleural effusion is present in 50% to 80% of patients with acute heart failure, depending on image modality. We aim to describe the association between the presence and size of pleural effusion and central hemodynamics, including pulmonary capillary wedge pressure (PCWP) in an advanced heart failure population.</p><p><strong>Methods: </strong>An observational, cross-sectional study in a cohort of patients with advanced heart failure (left ventricular ejection fraction ≤45%) who underwent right heart catheterization at The Department of Cardiology at Copenhagen University Hospital, Rigshospitalet, Denmark, between January 1, 2002 and October 31, 2020. The presence and size of pleural effusion were determined by a semiquantitative score of chest <i>x</i>-rays or computed tomography scans performed within 2 days of right heart catheterization.</p><p><strong>Results: </strong>In 346 patients (50±13 years; 78% males) with median left ventricular ejection fraction of 20% (15-25), we identified 162 (47%) with pleural effusion. The pleural effusion size was medium in 38 (24%) and large in 30 (19%). Patients with pleural effusion had a 4.3 mm Hg (2.5-6.1) higher PCWP and 2.4 mm Hg (1.2-3.6) higher central venous pressure (<i>P</i><0.001 for both). Patients with a medium/large pleural effusion had statistically significantly higher filling pressures than patients with a small effusion. Higher PCWP (odds ratio [OR], 1.06 [1.03-1.10]) and central venous pressure (OR, 1.09 [1.05-1.15]) were associated with pleural effusion in multivariable logistic regression adjusted for age, sex, and heart failure medications (<i>P</i><0.001 for both). In a subgroup of 204 (63%) patients with serum albumin data, PCWP (OR, 1.06 [1.01-1.11]; <i>P</i>=0.032), central venous pressure (OR, 1.14 [1.06-1.23]; <i>P</i><0.001) and serum albumin level (OR, 0.89 [0.83-0.95]; <i>P</i><0.001) were independently associated with the presence of a medium/large-sized pleural effusion.</p><p><strong>Conclusions: </strong>In patients with left ventricular ejection fraction ≤45% undergoing right heart catheterization as part of advanced heart failure work-up, pleural effusion was associated with higher PCWP and central venous pressure and lower serum albumin.</p>","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":" ","pages":"e011253"},"PeriodicalIF":7.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141892999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Circulation: Heart Failure
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1